LA Private

Uncategorized

Stocks of the Hour: Immutep, Pointerra, Zeus Resources

First Patient Dosed in Chemotherapy-Free Triple Combination Phase II Trial Targeting Soft Tissue Sarcoma Immutep (ASX:IMM; NASDAQ:IMMP) announced that the first patient has been dosed in the Chemotherapy-free Combination Phase II Trial Targeting Sarcoma, a disease in which malignant (cancer) cells form in the soft tissues of the body. In response, Immutep CSO, Frédéric Triebe

Stocks of the Hour: Immutep, Pointerra, Zeus Resources Read More »

Japan and South Korea decline offer to join $44 billion LNG project

Japan and South Korea have rejected US overtures to join the proposed $44 billion Alaska natural-gas project, which could be one of the most significant energy investments in American history. The project, known as Alaska LNG, involves an 807-mile pipeline transporting natural gas from fields north of the Arctic Circle to the southern part of

Japan and South Korea decline offer to join $44 billion LNG project Read More »

Liontown on track for first production for Kathleen Valley lithium project

Liontown Resources’ (ASX:LTR) Kathleen Valley Lithium Project is well on track for its first production by mid-2024, as the company achieved significant milestones during the June quarter. The project is witnessing a surge in mining and construction activities, with key developments in the process plant and power station infrastructure build. Safety remains a top priority

Liontown on track for first production for Kathleen Valley lithium project Read More »